Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1

Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 is an extended-release capsule designed for oral use. It contains a combination of amphetamine salts, commonly used for attention deficit hyperactivity disorder (ADHD) management. This medication is manufactured by SpecGx LLC in the USA.

Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 is primarily used for the treatment of ADHD. The extended-release formulation is designed to provide a steady release of the active ingredients over time, which may help in managing symptoms throughout the day. This medication is often prescribed to improve focus, attention, and impulse control in individuals with ADHD.

Common effects of Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 may include increased alertness, improved concentration, and reduced hyperactivity. Some users may experience side effects such as decreased appetite, insomnia, or mild stomach upset. The extended-release formulation is intended to minimize fluctuations in drug levels, potentially reducing the likelihood of side effects.

It is important to handle Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 with care, following the prescribed dosage and administration instructions. This medication should be stored in a cool, dry place away from direct sunlight and out of reach of children. Always consult a healthcare provider before starting or stopping any medication.

Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 may interact with certain medications, including other stimulants, antidepressants, and some over-the-counter cold and allergy medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.